Sanofi India expands its consumer healthcare portfolio with a new addition in the pain-care segment - Combiflam ICYHOT, a topical analgesic. This over-the-counter (OTC) product is available in two formats: gel and spray, for instant and long-lasting relief to people suffering from muscle pains and sprains.
On application of Combiflam ICYHOT, it produces an icy and a hot sensation. The icy action reduces the pain, while the hot action relaxes stiff muscles to give effective pain relief.
Combiflam is one of our flagship prescription brands and is present in 1 of 3 Indian households. Building on this legacy, the launch of Combiflam ICYHOT gel and spray in the OTC segment further expands our consumer healthcare portfolio,” said Dr. Shailesh Ayyangar, Managing Director - India and Vice President - South Asia, Sanofi.
In a survey conducted by IPSOS in India, every person admitted to suffering from some kind of pain in the last 12 months, but only 43% of the pain occasions were treated with an available painkiller at home.[1]
According to Nikhilesh Kalra, General Manager, Consumer Healthcare, India & South Asia typically, when it comes to seeking relief from muscular pains including neck, shoulder and back pain, topicals are the most preferred format. To address this gap in our pain segment, we have brought the ICYHOT® brand from Sanofi USA, and are manufacturing it indigenously to offer our Indian consumers a high quality over-the-counter product, at affordable prices.”
It gel is available in packs of 15g and 30g and priced at Rs. 50 and Rs. 98 respectively. The spray is available in packs of 35g and 55g and priced at Rs. 115 and Rs. 175 respectively across chemists, on e-commerce websites and licensed modern trade.
Sanofi’s Consumer Healthcare Business Unit has a strong presence in four segments, i.e. pain-care, digestive health, allergy solutions, and vitamins, minerals & supplements.